| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$207,021,051 |
|
|
|
Indirect Value
|
$177,439,906 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$384,460,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-05-28 |
4 |
B |
$2.05 |
$381,787 |
D/D |
186,684 |
4,161,193 |
2.45 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-27 |
4 |
B |
$2.05 |
$204,580 |
I/I |
100,000 |
431,811 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-05 |
4 |
B |
$2.05 |
$97,026 |
I/I |
47,293 |
690,547 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-19 |
4 |
S |
$2.05 |
$61,078 |
I/I |
(29,723) |
10,974,532 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-26 |
4 |
S |
$2.05 |
$26,209 |
I/I |
(12,763) |
10,840,517 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-27 |
4 |
S |
$2.05 |
$205 |
I/I |
(100) |
10,840,417 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-05-27 |
4 |
B |
$2.06 |
$412,680 |
D/D |
200,000 |
3,974,509 |
2.45 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-25 |
4 |
S |
$2.06 |
$26,363 |
I/I |
(12,818) |
10,853,280 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-05 |
4 |
S |
$2.06 |
$14,420 |
I/I |
(7,000) |
701,858 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-12 |
4 |
B |
$2.08 |
$12,496 |
I/I |
6,000 |
698,647 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-29 |
4 |
B |
$2.09 |
$23,492 |
I/I |
11,243 |
452,024 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-03 |
4 |
B |
$2.09 |
$20,871 |
I/I |
10,000 |
613,254 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-22 |
4 |
S |
$2.09 |
$151,592 |
I/I |
(72,591) |
10,866,098 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-02 |
4 |
B |
$2.10 |
$14,232 |
D/D |
6,779 |
4,211,288 |
2.37 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-20 |
4 |
S |
$2.10 |
$42,484 |
I/I |
(20,277) |
10,954,255 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-21 |
4 |
S |
$2.10 |
$32,642 |
I/I |
(15,566) |
10,938,689 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-28 |
4 |
B |
$2.11 |
$18,936 |
I/I |
8,970 |
440,781 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-15 |
4 |
S |
$2.11 |
$74,436 |
I/I |
(35,231) |
4,460,894 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-02-03 |
4 |
S |
$2.13 |
$31,312 |
I/I |
(14,700) |
4,446,194 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-04 |
4 |
B |
$2.14 |
$64,197 |
I/I |
30,000 |
643,254 |
1.5 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-02 |
4 |
S |
$2.19 |
$6,570 |
I/I |
(3,000) |
708,858 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-26 |
4 |
B |
$2.23 |
$95,415 |
I/I |
42,745 |
331,811 |
1.5 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2017-12-19 |
4 |
B |
$2.26 |
$4,309,241 |
I/I |
1,906,744 |
3,270,481 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-25 |
4 |
B |
$2.31 |
$69,347 |
I/I |
30,014 |
289,066 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-21 |
4 |
B |
$2.32 |
$258,275 |
I/I |
111,407 |
111,407 |
1.5 |
- |
|
634 Records found
|
|
Page 11 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
